CN103285363A - Drug for treating xerophthalmia with cervical spondylosis - Google Patents

Drug for treating xerophthalmia with cervical spondylosis Download PDF

Info

Publication number
CN103285363A
CN103285363A CN2013102572284A CN201310257228A CN103285363A CN 103285363 A CN103285363 A CN 103285363A CN 2013102572284 A CN2013102572284 A CN 2013102572284A CN 201310257228 A CN201310257228 A CN 201310257228A CN 103285363 A CN103285363 A CN 103285363A
Authority
CN
China
Prior art keywords
parts
fructus
herba
rhizoma
pericarpium citri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013102572284A
Other languages
Chinese (zh)
Other versions
CN103285363B (en
Inventor
王次霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310257228.4A priority Critical patent/CN103285363B/en
Publication of CN103285363A publication Critical patent/CN103285363A/en
Application granted granted Critical
Publication of CN103285363B publication Critical patent/CN103285363B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a drug for treating xerophthalmia with cervical spondylosis. The drug is prepared from the following substances by weight ratio: root of common peony, semen raphani, white hyacinth bean, chinaroot greenbrier, mung bean, peucedanum decursivum maxim, monthly rose, tuber fleeceflower stem, Chinese yam, lilac bark, sea-tangle, thlaspi arvense, pericarpium citri reticulatae viride, rhizoma zingiberis, sauropus spatulifolius, pterocephalus hookeri heck, oriental wormwood, witloof, white atractylodes rhizome, dandelion, loofah sponge, pawpaw, hawthorn, prepared rehmannia root, dioscorea spongiosa, orange peel, sweetgum fruit, polygonum perfoliatum, fructus broussonetiae, justicia gendarussa, moutan bark, angelica sinensis, rhizoma nelumbinis, herba siegesbeckiae, medulla dtachyuri, jasmine, pericarpium citri reticulatae, radix bupleuri, Chinese mahonia stem, piper cubeba, concha arcae, poria cocos, cassia twig, rhizoma cyperi, caulis spatholobi and fructus citri. The drug for treating xerophthalmia with cervical spondylosis is prepared from natural drugs, is accurate in curative effect, and can effectively treat xerophthalmia with cervical spondylosis. Therefore, the drug is suitable for clinical popularization.

Description

A kind of medicament for the treatment of xerophthalmia companion cervical spondylosis
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of xerophthalmia companion cervical spondylosis.
Background technology
Xerophthalmia is being commonly called as of angle conjunctival xerosis, be a kind of conjunctiva cornea can not be moistening, be the general name of the various disease conditions of feature with eye table pathological changes.And cervical spondylosis refers to the comprehensive syndrome because the cervical vertebra regression stimulates or compressing cervical nerves, spinal cord, blood vessel, sympathetic nerve and its surrounding soft tissue cause.In clinical position, find that xerophthalmia and cervical spondylosis have very big dependency.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of xerophthalmia companion cervical spondylosis.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of xerophthalmia companion cervical spondylosis, it is to be made by following materials by weight: Radix Paeoniae Rubra 20-30 part, Semen Raphani 10-20 part, Semen Lablab Album 30-40 part, Rhizoma Smilacis Chinensis 10-20 part, Semen phaseoli radiati 15-30 part, RADIX PEUCEDANI 1-10 part, Flos Rosae Chinensis 20-40 part, Caulis Polygoni Multiflori 1-20 part, Rhizoma Dioscoreae 20-30 part, Cortex Syingae Amurensis 1-20 part, Thallus Laminariae (Thallus Eckloniae) 20-30 part Herba Thlaspis 10-30 part, Pericarpium Citri Reticulatae Viride 10-30 part, Rhizoma Zingiberis 20-30 part, Folium Sauropi 10-20 part, Herba pterocephali 5-15 part, Herba Artemisiae Scopariae 1-10 part, Herba Cichorii 15-25 part, Rhizoma Atractylodis Macrocephalae 15-40 part, Herba Taraxaci 10-30 part, Retinervus Luffae Fructus 1-20 part, Fructus Chaenomelis 5-15 part, Fructus Crataegi 20-40 part, Radix Rehmanniae Preparata 30-50 part Rhizoma Dioscoreae Septemlobae 10-20 part, Pericarpium Citri tangerinae 10-20 part, Fructus Liquidambaris 20-30 part, Herba Polygoni cymosi 10-30 part, Fructus Broussonetiae 1-20 part, Herba Gendarussae 10-20 part, Cortex Moutan 10-30 part, Radix Angelicae Sinensis 1-15 part, Nodus Nelumbinis Rhizomatis 10-20 part Herba Siegesbeckiae 10-20 part, Medulla Stachyuri (Medulla Helwingiae) 20-30 part, Fructus Gardeniae 20-40 part, Pericarpium Citri Reticulatae 1-20 part, Radix Bupleuri 20-30 part, Caulis Mahoniae 1-10 part, Fructus Litseae 20-30 part, Concha Arcae 1-20 part, Poria 1-20 part, Ramulus Cinnamomi 10-20 part, Rhizoma Cyperi 1-10 part, Caulis Spatholobi 10-20 part and Fructus Citri 20-40 part.
Preferably, the medicament for the treatment of xerophthalmia companion cervical spondylosis of the present invention is to be made by following materials by weight: 25 parts of Radix Paeoniae Rubra, 15 parts of Semen Raphanis, 30 parts of Semen Lablab Albums, 15 parts of Rhizoma Smilacis Chinensiss, 20 parts in Semen phaseoli radiati, 5 parts of RADIX PEUCEDANI, 20 parts of Flos Rosae Chinensiss, 10 parts of Caulis Polygoni Multiflori, 30 parts of Rhizoma Dioscoreaes, 10 parts of Cortex Syingae Amurensiss, 20 parts of 30 parts of Herba Thlaspiss of Thallus Laminariae (Thallus Eckloniae), 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Rhizoma Zingiberiss, 10 parts of Folium Sauropis, 10 parts of Herba pterocephali, 5 parts of Herba Artemisiae Scopariaes, 20 parts of Herba Cichoriis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Herba Taraxacis, 10 parts of Retinervus Luffae Fructuss, 10 parts of Fructus Chaenomeliss, 30 parts of Fructus Crataegis, 15 parts of 40 parts of Rhizoma Dioscoreae Septemlobaes of Radix Rehmanniae Preparata, 15 parts of Pericarpium Citri tangerinaes, 25 parts of Fructus Liquidambaris, 20 parts of Herba Polygoni cymosis, 10 parts of Fructus Broussonetiaes, 15 parts of Herba Gendarussaes, 20 parts of Cortex Moutans, 10 parts of Radix Angelicae Sinensis, 15 parts of 15 parts of Herba Siegesbeckiaes of Nodus Nelumbinis Rhizomatis, 25 parts of Medulla Stachyuri (Medulla Helwingiae)s, 30 parts of Fructus Gardeniaes, 10 parts of Pericarpium Citri Reticulataes, 25 parts of Radix Bupleuri, 5 parts of Caulis Mahoniaes, 25 parts of Fructus Litseae, 10 parts of Concha Arcaes, 10 parts in Poria, 15 parts of Ramulus Cinnamomi, 5 parts of Rhizoma Cyperis, 30 parts of 15 parts of Caulis Spatholobis and Fructus Citris.
More preferably, described medicament is tablet, dispersible tablet, decoction or liniment.
The medicament for the treatment of xerophthalmia companion cervical spondylosis of the present invention all adopts natural drug to make, and curative effect is clear and definite, can treat xerophthalmia companion cervical spondylosis effectively, therefore very suitable popularization clinically.
The specific embodiment
Further specify the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent among the present invention is percetage by weight.
The preparation of embodiment 1 decoction
Get Radix Paeoniae Rubra 25 grams, Semen Raphani 15 grams, Semen Lablab Album 30 grams, Rhizoma Smilacis Chinensis 15 grams, Semen phaseoli radiati 20 grams, RADIX PEUCEDANI 5 grams, Flos Rosae Chinensis 20 grams, Caulis Polygoni Multiflori 10 grams, Rhizoma Dioscoreae 30 grams, Cortex Syingae Amurensis 10 grams, Thallus Laminariae (Thallus Eckloniae) 30 gram Herba Thlaspiss 20 grams, Pericarpium Citri Reticulatae Viride 20 grams, Rhizoma Zingiberis 20 grams, Folium Sauropi 10 grams, Herba pterocephali 10 grams, Herba Artemisiae Scopariae 5 grams, Herba Cichorii 20 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Herba Taraxaci 20 grams, Retinervus Luffae Fructus 10 grams, Fructus Chaenomelis 10 grams, Fructus Crataegi 30 grams, Radix Rehmanniae Preparata 40 gram Rhizoma Dioscoreae Septemlobaes 15 grams, Pericarpium Citri tangerinae 15 grams, Fructus Liquidambaris 25 grams, Herba Polygoni cymosi 20 grams, Fructus Broussonetiae 10 grams, Herba Gendarussae 15 grams, Cortex Moutan 20 grams, Radix Angelicae Sinensis 10 grams, Nodus Nelumbinis Rhizomatis 15 gram Herba Siegesbeckiaes 15 grams, Medulla Stachyuri (Medulla Helwingiae) 25 grams, Fructus Gardeniae 30 grams, Pericarpium Citri Reticulatae 10 grams, Radix Bupleuri 25 grams, Caulis Mahoniae 5 grams, Fructus Litseae 25 grams, Concha Arcae 10 grams, Poria 10 grams, Ramulus Cinnamomi 15 grams, Rhizoma Cyperi 5 grams, Caulis Spatholobi 15 grams and Fructus Citri 30 grams, add 5000 ml waters, heated 3 hours down at 100 ℃, be cooled to room temperature.Filter, filtrate is concentrated into 800 milliliters, is cooled to room temperature, is decoction of the present invention.
Experimental example
1.1 physical data
The patient amounts to 50 examples, male 25 examples, and women 25 examples, the age is 17-65 year, average 50.6 years old.All case is come the outpatient service xerophthalmia companion cervical spondylosis patient of self-sizing.Xerophthalmia course of disease weak point person 3-5 days, existing more than 1 year of elder.
1.2 diagnostic criteria
1. all patients all possess the clinical manifestation of canthus conjunctival xerosis.This research does not comprise obvious trachoma, keratitis, eye chemical injury patient, does not comprise the caused xerophthalmia patients of essence pathological changes such as upper eyelid skin ulcer and blepharocoloboma, ectropion of lid.2. all patients that meet above condition confirm as the cervical spondylosis patient all through the inspection of cervical vertebra X sheet anterioposterior and lateral film.The X sheet shows visible cervical vertebral body hyperosteogeny, the uncovertebral joint hypertrophy, and physiology is bent degree and is become straight, the articuli intervertebrales shakiness, the ligament calcification, pathologic such as intervertebral disc degradation change.3. often with diseases such as dizziness, tinnitus, hypomnesis, neck, shoulder back swelling and pain medical history are arranged more.4. get rid of intracranial space-occupying lesion.
Use the decoction of embodiment 1 preparation to treat, 2 times on the one, take 50 milliliters at every turn, treating 10 days continuously is a course for the treatment of.
Efficacy assessment standard
Cure: clinical symptoms and sign complete obiteration;
Produce effects: eye symptom obviously improves, and dizziness, giddy and nape portion ache and alleviate substantially;
Take a turn for the better: eye, head, neck symptom all before alleviate;
Invalid: clinical symptoms, sign do not have obvious improvement.
The result
After treatment, find 50 routine patients' clinical symptoms and sign complete obiteration, therefore all meet the efficacy assessment standard of healing.
Untoward reaction
In therapeutic process, carry out tracing observation for the patient, do not find tangible untoward reaction.

Claims (3)

1. treat the medicament that xerophthalmia is accompanied cervical spondylosis for one kind, it is characterized in that it is to be made by following materials by weight: Radix Paeoniae Rubra 20-30 part, Semen Raphani 10-20 part, Semen Lablab Album 30-40 part, Rhizoma Smilacis Chinensis 10-20 part, Semen phaseoli radiati 15-30 part, RADIX PEUCEDANI 1-10 part, Flos Rosae Chinensis 20-40 part, Caulis Polygoni Multiflori 1-20 part, Rhizoma Dioscoreae 20-30 part, Cortex Syingae Amurensis 1-20 part, Thallus Laminariae (Thallus Eckloniae) 20-30 part Herba Thlaspis 10-30 part, Pericarpium Citri Reticulatae Viride 10-30 part, Rhizoma Zingiberis 20-30 part, Folium Sauropi 10-20 part, Herba pterocephali 5-15 part, Herba Artemisiae Scopariae 1-10 part, Herba Cichorii 15-25 part, Rhizoma Atractylodis Macrocephalae 15-40 part, Herba Taraxaci 10-30 part, Retinervus Luffae Fructus 1-20 part, Fructus Chaenomelis 5-15 part, Fructus Crataegi 20-40 part, Radix Rehmanniae Preparata 30-50 part Rhizoma Dioscoreae Septemlobae 10-20 part, Pericarpium Citri tangerinae 10-20 part, Fructus Liquidambaris 20-30 part, Herba Polygoni cymosi 10-30 part, Fructus Broussonetiae 1-20 part, Herba Gendarussae 10-20 part, Cortex Moutan 10-30 part, Radix Angelicae Sinensis 1-15 part, Nodus Nelumbinis Rhizomatis 10-20 part Herba Siegesbeckiae 10-20 part, Medulla Stachyuri (Medulla Helwingiae) 20-30 part, Fructus Gardeniae 20-40 part, Pericarpium Citri Reticulatae 1-20 part, Radix Bupleuri 20-30 part, Caulis Mahoniae 1-10 part, Fructus Litseae 20-30 part, Concha Arcae 1-20 part, Poria 1-20 part, Ramulus Cinnamomi 10-20 part, Rhizoma Cyperi 1-10 part, Caulis Spatholobi 10-20 part and Fructus Citri 20-40 part.
2. treatment xerophthalmia according to claim 1 is accompanied the medicament of cervical spondylosis, it is characterized in that it is to be made by following materials by weight: 25 parts of Radix Paeoniae Rubra, 15 parts of Semen Raphanis, 30 parts of Semen Lablab Albums, 15 parts of Rhizoma Smilacis Chinensiss, 20 parts in Semen phaseoli radiati, 5 parts of RADIX PEUCEDANI, 20 parts of Flos Rosae Chinensiss, 10 parts of Caulis Polygoni Multiflori, 30 parts of Rhizoma Dioscoreaes, 10 parts of Cortex Syingae Amurensiss, 20 parts of 30 parts of Herba Thlaspiss of Thallus Laminariae (Thallus Eckloniae), 20 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Rhizoma Zingiberiss, 10 parts of Folium Sauropis, 10 parts of Herba pterocephali, 5 parts of Herba Artemisiae Scopariaes, 20 parts of Herba Cichoriis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Herba Taraxacis, 10 parts of Retinervus Luffae Fructuss, 10 parts of Fructus Chaenomeliss, 30 parts of Fructus Crataegis, 15 parts of 40 parts of Rhizoma Dioscoreae Septemlobaes of Radix Rehmanniae Preparata, 15 parts of Pericarpium Citri tangerinaes, 25 parts of Fructus Liquidambaris, 20 parts of Herba Polygoni cymosis, 10 parts of Fructus Broussonetiaes, 15 parts of Herba Gendarussaes, 20 parts of Cortex Moutans, 10 parts of Radix Angelicae Sinensis, 15 parts of 15 parts of Herba Siegesbeckiaes of Nodus Nelumbinis Rhizomatis, 25 parts of Medulla Stachyuri (Medulla Helwingiae)s, 30 parts of Fructus Gardeniaes, 10 parts of Pericarpium Citri Reticulataes, 25 parts of Radix Bupleuri, 5 parts of Caulis Mahoniaes, 25 parts of Fructus Litseae, 10 parts of Concha Arcaes, 10 parts in Poria, 15 parts of Ramulus Cinnamomi, 5 parts of Rhizoma Cyperis, 30 parts of 15 parts of Caulis Spatholobis and Fructus Citris.
3. the medicament for the treatment of xerophthalmia companion cervical spondylosis according to claim 1 and 2 is characterized in that described medicament is tablet, dispersible tablet, decoction or liniment.
CN201310257228.4A 2013-06-26 2013-06-26 Drug for treating xerophthalmia with cervical spondylosis Expired - Fee Related CN103285363B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310257228.4A CN103285363B (en) 2013-06-26 2013-06-26 Drug for treating xerophthalmia with cervical spondylosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310257228.4A CN103285363B (en) 2013-06-26 2013-06-26 Drug for treating xerophthalmia with cervical spondylosis

Publications (2)

Publication Number Publication Date
CN103285363A true CN103285363A (en) 2013-09-11
CN103285363B CN103285363B (en) 2014-10-08

Family

ID=49087252

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310257228.4A Expired - Fee Related CN103285363B (en) 2013-06-26 2013-06-26 Drug for treating xerophthalmia with cervical spondylosis

Country Status (1)

Country Link
CN (1) CN103285363B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103989887A (en) * 2014-06-12 2014-08-20 伏广珍 Pharmaceutical composition for treating orthopedic diseases as well as preparation method and application thereof
CN104435516A (en) * 2014-11-27 2015-03-25 邹士东 Traditional Chinese medicine combination for treating liver-kidney yin deficiency type xerophthalmia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537168A (en) * 2009-02-03 2009-09-23 王峰 Traditional Chinese medicine composition for treatment of cervical spondylopathy and osteoarticular diseases and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537168A (en) * 2009-02-03 2009-09-23 王峰 Traditional Chinese medicine composition for treatment of cervical spondylopathy and osteoarticular diseases and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张天真等: "治痹十法", 《辽宁中医杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103989887A (en) * 2014-06-12 2014-08-20 伏广珍 Pharmaceutical composition for treating orthopedic diseases as well as preparation method and application thereof
CN104435516A (en) * 2014-11-27 2015-03-25 邹士东 Traditional Chinese medicine combination for treating liver-kidney yin deficiency type xerophthalmia

Also Published As

Publication number Publication date
CN103285363B (en) 2014-10-08

Similar Documents

Publication Publication Date Title
CN103223072B (en) Chinese medicinal formula for treating cervical disc herniation and lumbar disc herniation
CN103316174A (en) Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof
CN1539479A (en) Drug for curing disease of proplapse of lumbar intervertebral disc
CN101897821B (en) Granular preparation for promoting blood circulation, dredging collaterals and relieving pain and preparation method as well as detection method thereof
CN103285363B (en) Drug for treating xerophthalmia with cervical spondylosis
CN103446554A (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN102008551B (en) Medicinal composition for treating pains of necks, shoulders and arms and preparation method and application thereof
CN106309533A (en) Traditional chinese medicine composition and application thereof
CN103989999A (en) Traditional Chinese medicinal preparation for treating spinal tuberculosis and preparation method thereof
CN101095790A (en) Chinese traditional medicine composition for treating anxiety disease and method of making the same
CN110893228B (en) Shenque-Mingmen combined patch
CN103705864B (en) A kind of steaming bone hot compress plaster for the treatment of cervical vertebra, lumbar spondylosis
CN102772617B (en) Medicine for treating disease of hyperosteogeny
CN103550470B (en) Healthy traditional Chinese medicine for children
CN105998546A (en) Traditional Chinese medicine composition
CN102813746B (en) Traditional Chinese medicine composition for treating numbness of fingers
CN104940806A (en) Liquid medicine for treating sclerotin
CN104258295A (en) Traditional Chinese medicine decoction for treating lymphoma
CN104491717B (en) A kind of medicine for treating the proliferation of mammary gland
CN104056206A (en) Refreshing, depression-resolving and tranquilizing preparation
CN1062172C (en) Medicine for treating cervical spondylopathy
CN102784360B (en) Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spine bone hyperplasia
CN102836316A (en) Chinese medicine preparation for treating amblyopia
CN105796749A (en) Acupoint massage and traditional Chinese medicine composition for relieving asthenopia
CN105343741A (en) Traditional Chinese medicine for treating thyroid tumor and preparation method of traditional Chinese medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141008

Termination date: 20150626

EXPY Termination of patent right or utility model